search
Back to results

hBET for Pain and Sleep Feasibility

Primary Purpose

Pain, Chronic, Sleep Disturbance

Status
Completed
Phase
Not Applicable
Locations
United Kingdom
Study Type
Interventional
Intervention
home-based Brainwave Entrainment Technology
Sponsored by
University of Manchester
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Pain, Chronic focused on measuring audio-visual stimulation, brainwave entrainment

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Chronic non-cancer pain (recurring pain ≥ 3 months duration)
  • Having nocturnal pain (NRS 0-10 worst pain ≥ 4)
  • Self-reported sleep difficulties (trouble falling asleep, difficulty staying asleep, waking up too early, or waking up unrefreshed) 3 or more nights per week during the past month

Exclusion Criteria:

  • Planned intervention (injection/ surgery/ new oral medications for pain or sleep) during the 4-week hBET use period
  • Seizure disorder
  • Photosensitivity
  • Hearing or sight problems causing inability to use hBET
  • Cognitive problems or dementia or mental health disorders causing inability to consent

Sites / Locations

  • University of Manchester

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Home based intervention

Arm Description

Participants using hBET technology at home (all participants).

Outcomes

Primary Outcome Measures

Qualitative semi-structured interviews
Interview at end of intervention period, following an interview guide, with responses thematically analysed

Secondary Outcome Measures

Sleep and pain diary
Bespoke daily diary recording self reported pain and sleep
Actigraphy
Motion watch-based objective measure of gross sleep temporal parameters (total sleep time, sleep latency, wakenings after sleep onset, sleep efficiency)
Brief Pain Inventory
Gives two scores of 0-10 for pain severity and pain interference respectively, with 10 being worst in both cases.
Pittsburgh Sleep Quality Index
Gives a score of 0-21 with higher score indicating worse sleep quality
Hospital Anxiety and Depression Scale
Gives two scores of 0-21 for depression and anxiety respectively, with 21 being worst in both cases
Multidimensional Fatigue Inventory
Gives a score of 20-100, with higher scores indicating a higher level of fatigue
EuroQol 5 Dimensions (EQ-5D-5L)
A measure of global health state, providing a score of 1-5 in each of 5 domains (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), a global index score derived from population references ranging from 0-1 and a self reported description of overall health status on a 0-100 visual-analogue scale

Full Information

First Posted
November 18, 2019
Last Updated
May 15, 2023
Sponsor
University of Manchester
Collaborators
University of Leeds
search

1. Study Identification

Unique Protocol Identification Number
NCT04176861
Brief Title
hBET for Pain and Sleep Feasibility
Official Title
Home-based Brainwave Entrainment Technology (hBET) for Management of Chronic Pain and Sleep Disturbance: A Feasibility Study.
Study Type
Interventional

2. Study Status

Record Verification Date
May 2023
Overall Recruitment Status
Completed
Study Start Date
January 20, 2020 (Actual)
Primary Completion Date
December 31, 2021 (Actual)
Study Completion Date
December 31, 2021 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Manchester
Collaborators
University of Leeds

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
Long-term pain affects one-third of the United Kingdom population and can be very disabling. People experiencing long-term pain often suffer from disturbed sleep because of their pain symptoms, and disturbed sleep can then make their pain symptoms worse. Managing long-term pain is also very costly to the National Health Service. The most common treatment is prescribed medicines, but these do not always work and can have serious side-effects for some patients. The investigators have been developing an alternative approach for treating long-term pain. This approach uses simple non-invasive tools to promote some kinds of brain activity over others. It involves patients using headphones to listen to some specific sounds, or a headset with lights flashing at particular frequencies. The studies undertaken so far seem to show that doing this can change how the brain responds to pain. It potentially offers an inexpensive yet effective way of reducing pain and improving sleep for patients with long-term pain. There are a few small studies that support this approach and more work is needed. The next step is to find out whether these tools can be reliably used in home settings, how people feel about using this approach, and to gather information to design a larger trial of this technology. Therefore the aim of this study is to test the suitability and acceptability of these home-based tools with individuals with long-term pain. Up to 30 participants with long-term pain and pain-related sleep disturbance will use the tools for at least 20 minutes at bed time every day for 4 weeks. The investigators will interview them to ask about their experiences of using the tools, and their feedback and suggestions on how the approach should be developed. The investigators will measure changes in the nature of participants' pain, sleep, fatigue and mood. These findings will inform the planning and design of a future much larger study to test this technology. The investigators will make sure that findings from this study are shared widely within the National Health Service and beyond among patient groups, professionals, charities, specialist centres and commissioners.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Pain, Chronic, Sleep Disturbance
Keywords
audio-visual stimulation, brainwave entrainment

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
28 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Home based intervention
Arm Type
Experimental
Arm Description
Participants using hBET technology at home (all participants).
Intervention Type
Device
Intervention Name(s)
home-based Brainwave Entrainment Technology
Intervention Description
Smartphone app-based brainwave entrainment programme using audio stimulation via binaural beats or visual stimulation via flickering lights
Primary Outcome Measure Information:
Title
Qualitative semi-structured interviews
Description
Interview at end of intervention period, following an interview guide, with responses thematically analysed
Time Frame
5 weeks
Secondary Outcome Measure Information:
Title
Sleep and pain diary
Description
Bespoke daily diary recording self reported pain and sleep
Time Frame
5 weeks
Title
Actigraphy
Description
Motion watch-based objective measure of gross sleep temporal parameters (total sleep time, sleep latency, wakenings after sleep onset, sleep efficiency)
Time Frame
5 weeks
Title
Brief Pain Inventory
Description
Gives two scores of 0-10 for pain severity and pain interference respectively, with 10 being worst in both cases.
Time Frame
5 weeks
Title
Pittsburgh Sleep Quality Index
Description
Gives a score of 0-21 with higher score indicating worse sleep quality
Time Frame
5 weeks
Title
Hospital Anxiety and Depression Scale
Description
Gives two scores of 0-21 for depression and anxiety respectively, with 21 being worst in both cases
Time Frame
5 weeks
Title
Multidimensional Fatigue Inventory
Description
Gives a score of 20-100, with higher scores indicating a higher level of fatigue
Time Frame
5 weeks
Title
EuroQol 5 Dimensions (EQ-5D-5L)
Description
A measure of global health state, providing a score of 1-5 in each of 5 domains (mobility, self-care, usual activities, pain/discomfort and anxiety/depression), a global index score derived from population references ranging from 0-1 and a self reported description of overall health status on a 0-100 visual-analogue scale
Time Frame
5 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
80 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Chronic non-cancer pain (recurring pain ≥ 3 months duration) Having nocturnal pain (NRS 0-10 worst pain ≥ 4) Self-reported sleep difficulties (trouble falling asleep, difficulty staying asleep, waking up too early, or waking up unrefreshed) 3 or more nights per week during the past month Exclusion Criteria: Planned intervention (injection/ surgery/ new oral medications for pain or sleep) during the 4-week hBET use period Seizure disorder Photosensitivity Hearing or sight problems causing inability to use hBET Cognitive problems or dementia or mental health disorders causing inability to consent
Facility Information:
Facility Name
University of Manchester
City
Manchester
State/Province
England
ZIP/Postal Code
M13 9PL
Country
United Kingdom

12. IPD Sharing Statement

Plan to Share IPD
No

Learn more about this trial

hBET for Pain and Sleep Feasibility

We'll reach out to this number within 24 hrs